Insight into adipokines to optimize therapeutic effects of stem cell for tissue regeneration.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
04 2020
Historique:
received: 17 10 2019
revised: 18 01 2020
accepted: 20 01 2020
pubmed: 31 1 2020
medline: 26 8 2021
entrez: 31 1 2020
Statut: ppublish

Résumé

Stem cell therapy is considered as a promising regenerative medicine for repairing and treating damaged tissues and/or preventing various diseases. But there are still some obstacles such as low cell migration, poor stem cell engraftment and decreased cell survival that need to be overcome before transplantation. Therefore, a large body of studies has focused on improving the efficiency of stem cell therapy. For instance, preconditioning of stem cells has emerged as an effective strategy to reinforce therapeutic efficacy. Adipokines are signaling molecules, secreted by adipose tissue, which regulate a variety of biological processes in adipose tissue and other organs including the brain, liver, and muscle. In this review article, we shed light on the biological effects of some adipokines including apelin, oncostatin M, omentin-1 and vaspin on stem cell therapy and the most recent preclinical advances in our understanding of how these functions ameliorate stem cell therapy outcome.

Identifiants

pubmed: 32000014
pii: S1043-4666(20)30019-3
doi: 10.1016/j.cyto.2020.155003
pii:
doi:

Substances chimiques

Adipokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

155003

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Chiman Mohammadi (C)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Saba Sameri (S)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Rezvan Najafi (R)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: re.najafi@umsha.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH